All sponsors

Kailera

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING0
READOUTS ≤12 MONTHS2
Open Kailera on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Ribupatide
NCT07458269
P2Active, not recruitingObesity2642027-05
KAI-7535
NCT07497880
P2Active, not recruitingObesity; Overweight3062027-07-07
KaiNETIC-1
NCT07284875
P3Active, not recruitingObesity; Overweight25302028-02
KaiNETIC-3
NCT07284979
P3Active, not recruitingObesity12702028-03
KaiNETIC-2
NCT07284901
P3Active, not recruitingObesity With Diabetes; Overweight With Diabetes12702028-03-27